Cancer Trial Drugs
Dear Cancer Australia,
I would like to request information about cancer trials being conducted in Australia.
The information I'm looking for is about the type of trial drugs that are being used to treat breast, lung and skin cancer and their effects on patients. I would also like the findings and outcomes of these specific drug trials and how many trials were conducted for each.
The trial drugs that I would like to receive information on are:
Lung: CLDK378A2X01B and ARCTIC
Breast: ZMC-ARX788-101 and PIKNIC
Skin: A Phase 1b/2a and TVEC
Yours faithfully,
Alicia Camilleri
Dear Alicia,
FREEDOM OF INFORMATION REQUEST
I refer to your request of 20 February 2016 to Cancer Australia seeking access under the Freedom of Information Act 1982 (FOI Act) as set out in the email from you below:
Your request will be processed in accordance with the provisions of the FOI Act, under which, Cancer Australia is required by paragraph 15(5)(b) to take all reasonable steps to notify you of a decision not later than 30 calendar days after the above receipt date.
In the case of your request, the due date for a decision is 21 March 2016 unless the 30 day period is extended to consult a third party.
The time period may also be extended with your written agreement.
You can access the FOI Act at the following website:
http://www.comlaw.gov.au/Series/C2004A02...
Cancer Australia will be in contact with you in the near future about the processing of your request, including if we need to consult a third party. If you require clarification of any of the matters discussed in this email you should contact the undersigned on 02 9357 9400.
Regards
Bill Northcote
General Manager
Corporate Affairs
Cancer Australia
Level 14, 300 Elizabeth Street, Surry Hills NSW 2010
Locked Bag 3, Strawberry Hills NSW 2012
P: + 61 2 9357 9431 | M: 0427 412 538 | F: + 61 2 9357 9477
canceraustralia.gov.au
@CancerAustralia YouTube.com/canceraustralia Cancer Australia Strategic Plan 2014-19
DISCLAIMER
This message and its attachments may contain legally privileged and/or confidential information. If you are not the intended recipient, you must not disclose or use the information contained in it. If you have received this e-mail in error, please notify the sender immediately by return e-mail and delete the e-mail. Any content of this message and its attachments which does not relate to the official business of Cancer Australia must be taken not to have been sent or endorsed by Cancer Australia. No warranty is made that the e-mail or attachment(s) are free from computer virus or other defect.
Keep up-to-date with Cancer Australia's latest news through our e-newsletter.
Click here to subscribe to Cancer Australia Connect
Dear Ms Camilleri,
Please see attached notice of decision in regard to your FOI request on 20 February 2016.
Regards
Bill Northcote
General Manager
Corporate Affairs
Cancer Australia
Level 14, 300 Elizabeth Street, Surry Hills NSW 2010
Locked Bag 3, Strawberry Hills NSW 2012
P: + 61 2 9357 9431 | M: 0427 412 538 | F: + 61 2 9357 9477
canceraustralia.gov.au
@CancerAustralia YouTube.com/canceraustralia Cancer Australia Strategic Plan 2014-19
DISCLAIMER
This message and its attachments may contain legally privileged and/or confidential information. If you are not the intended recipient, you must not disclose or use the information contained in it. If you have received this e-mail in error, please notify the sender immediately by return e-mail and delete the e-mail. Any content of this message and its attachments which does not relate to the official business of Cancer Australia must be taken not to have been sent or endorsed by Cancer Australia. No warranty is made that the e-mail or attachment(s) are free from computer virus or other defect.
Keep up-to-date with Cancer Australia's latest news through our e-newsletter.
Click here to subscribe to Cancer Australia Connect